Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM)
9599 Background:In the EORTC 26981–22981/NCIC CE3 phase III trial, 573 pts with newly diagnosed GBM were randomized to receive radiotherapy (RT) or RT plus Temozolomide (results...